skip to main content

Aspirin secondary prevention — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyCardiovascular TherapeuticsAspirin secondary preventionGPhC CRA

A patient discharged after an NSTEMI presents with aspirin 75 mg once daily and asks why it is continued after leaving hospital. There is no aspirin allergy noted. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Continue aspirin for secondary prevention unless contraindicated

Low-dose aspirin is used for secondary prevention after acute coronary syndrome. Stopping without clinical review may increase thrombotic risk. In this scenario, the correct option is continue aspirin for secondary prevention unless contraindicated. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.

Reference: BNF; NICE CKS